論文

査読有り 責任著者 国際誌
2019年7月

Immunological consequences following splenectomy in patients with liver cirrhosis.

Experimental and therapeutic medicine
  • Yusuke Hirakawa
  • ,
  • Toshiro Ogata
  • ,
  • Tetsuro Sasada
  • ,
  • Takuto Yamashita
  • ,
  • Kyogo Itoh
  • ,
  • Hiroyuki Tanaka
  • ,
  • Koji Okuda

18
1
開始ページ
848
終了ページ
856
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.3892/etm.2019.7640

The immune status in patients with liver cirrhosis is generally impaired due to concomitant hypersplenism. As the spleen is the largest lymphoid organ, deleterious events resulting from splenectomy are of concern in these patients. However, the immunological consequences after splenectomy have not yet been fully elucidated. In the present study, the immune status after splenectomy was comprehensively examined. Splenectomy was performed in 11 patients with liver cirrhosis and hypersplenism, and the immune status in peripheral blood was examined and compared before and at 1, 3 and 6 months after splenectomy. Splenectomy significantly lowered the neutrophil-to-lymphocyte ratio, due to a surge in lymphocytes in the peripheral circulation at 3 and 6 months after splenectomy. The frequency of cluster of differentiation (CD)4+ T cells decreased after splenectomy, whereas the frequency of CD8+ T cells increased. Notably, the frequencies of the naïve and central memory subsets of CD4+ and CD8+ T cells decreased, whereas those of the effector memory subset trended upward. In addition, the frequencies of other immune cells such as γδ T cells, natural killer T cells and natural killer cells transiently increased, while inhibitory cells such as regulatory T cells and myeloid-derived suppressor cells significantly decreased. T-cell responses to viral- and tumor-associated antigens increased after splenectomy in five of eight and two of five patients, respectively. To the best of our knowledge, this is the first study to precisely examine the drastic changes of immunological phenotypes in peripheral blood after splenectomy in patients with cirrhosis. Our findings suggested that splenectomy in patients with cirrhosis may ameliorate the impaired immune status, possibly by reducing suppressive cells and enhancing the effector cell population and function, which could, at least in part, explain the mechanisms responsible for the clinical benefits of splenectomy.

リンク情報
DOI
https://doi.org/10.3892/etm.2019.7640
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/31281459
PubMed Central
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6591499
ID情報
  • DOI : 10.3892/etm.2019.7640
  • ISSN : 1792-0981
  • PubMed ID : 31281459
  • PubMed Central 記事ID : PMC6591499

エクスポート
BibTeX RIS